Abstract:Aim: To detect the level of thyroid hormone in patients with major depressive disorder and dysthymic disorder, and observe the biological significance of neuroendocrine changes in the patients with major depressive disorder and dysthymic disorder. Methods: Inpatients with major depressive disorder (n=30) and dysthymic disorder (n=30) were selected from the outpatient departments of psychiatry and neurology and the third inpatient division of the Department of Psychiatry, the First Clinical Hospital of Harbin Medical University, and Harbin First Specific Hospital between January and December 2004. They were assessed with Hamilton depression scale (HAMD), Eysenck personality questionnaire (EPQ) and life event scale (LES). The serum levels of 3,5,3-triiodothyronine (T 3), 3,5,3,5,-tetraiodotyyronine (T 4) and thyroid stimulating hormone (TSH) were determined with radioimmunoassay in both groups. Results: All the 30 patients with major depressive disorder and 30 patients with dysthymic disorder entered the analysis of results. 1 The total score of HAMD had completely significant difference between the groups (P=0.000), and there were significant differences in the factor scores of anxiety/somatization, cognitive impairment and retardation, and the neural scale in EPQ (P < 0.05). 2 The T 4 level was significantly different between the two groups. 3 In the patients with major depressive disorder, the T 3 level was positively correlated with the score of extraversion-introversion in EQP and the score of retardation in HAMD (r=0.0411, 0.426, P=0.024, 0.019); T 4 level was positively correlated with the total score of HAMD, score of anxiety, and the stimulative amount of negative life events (r=0.474, 0.416, 0.426, P=0.015, 0.022, 0.019); TSH was positively correlated with the stimulative amount of positive life events (r=0.433, P=0.017). In the patients with dysthymic disorder, T 3 level was negative correlated with the score of cognitive impairment (r=-0.509, P=0.004); T 4 level had positive correlation with the total score of HAMD, stimulative amount of negative life events and score of retardation (r=0.396, 0.420, 0.367, P=0.042, 0.021, 0.046). Conclusion: Negative life events accelerate the episode of depression, and T 4 level could be a useful predictor for the severity of depressive symptoms.

Relationship between thyroid-stimulating hormone and blood lipids in patients with first-episode depression

Association of thyroid function with abnormal lipid metabolism in young patients with first-episode and drug naïve major depressive disorder

The Impact of Quetiapine Monotherapy or in Combination with Lithium on the Thyroid Function in Patients with Bipolar Depression: A Retrospective Study

Thyroid dysfunction in young, first-episode and drug-naïve patients with major depressive disorder: prevalence and associated clinical factors

Prevalence and clinical correlates of thyroid dysfunction in first-episode and drug-naïve major depressive disorder patients with metabolic syndrome

Comparison of Thyroid Hormone Levels Between Patients With Major Depressive Disorder and Healthy Individuals in China

Comparison of Hair Thyroid Hormones Between First‐episode and Recurrent Patients with Depression in Female Chinese

Elevated thyroid stimulating hormone and metabolic syndrome risk in patients with first-episode and drug-naïve major depressive disorder: a large-scale cross-sectional study

Association between thyroid dysfunction, metabolic disturbances, and clinical symptoms in first-episode, untreated Chinese patients with major depressive disorder: Undirected and Bayesian network analyses

Association between fasting blood glucose and thyroid stimulating hormones and suicidal tendency and disease severity in patients with major depressive disorder

Hair thyroid hormones concentration in patients with depression changes with disease episodes in female Chinese

The relationship between overweight and thyroid function in first-episode, untreated Chinese patients with major depressive disorder with different ages of onset

Prevalence and risk factors of thyroid dysfunction in outpatients with overweight or obese first-episode and drug-naïve major depressive disorder

Prevalence and clinical correlates of abnormal lipid metabolism in first-episode and drug-naïve patients with major depressive disorder with abnormal glucose metabolism

Comparison of the level of thyroid hormones between patients with major depressive disorder and dysthymic disorder

Association between thyroid autoimmunity and clinical characteristics in first-episode and drug-naive depressed patients with suicide attempts

Changes in thyroid function levels in female patients with first-episode bipolar disorder

The Correlation Between Thyroid Function, Frontal Gray Matter, and Executive Function in Patients With Major Depressive Disorder

Clinical correlates of autoimmune thyroiditis and non-autoimmune hypothyroidism in treatment-naïve patients with major depressive disorders

The effect of thyroid function on the risk of psychiatric readmission after hospitalization for major depressive disorder

Exploring the potential of thyroid hormones to predict clinical improvements in depressive patients: A machine learning analysis of the real-world based study.